Intrinsic tumour suppression
- PMID: 15549092
- DOI: 10.1038/nature03098
Intrinsic tumour suppression
Abstract
Mutations that drive uncontrolled cell-cycle progression are requisite events in tumorigenesis. But evolution has installed in the proliferative programmes of mammalian cells a variety of innate tumour-suppressive mechanisms that trigger apoptosis or senescence, should proliferation become aberrant. These contingent processes rely on a series of sensors and transducers that act in a coordinated network to target the machinery responsible for apoptosis and cell-cycle arrest at different points. Although oncogenic mutations that disable such networks can have profound and varied effects on tumour evolution, they may leave intact latent tumour-suppressive potential that can be harnessed therapeutically.
Similar articles
-
p53 and breast cancer, an update.Endocr Relat Cancer. 2006 Jun;13(2):293-325. doi: 10.1677/erc.1.01172. Endocr Relat Cancer. 2006. PMID: 16728565 Review.
-
The role of DNA damage responses in p53 biology.Arch Toxicol. 2015 Apr;89(4):501-17. doi: 10.1007/s00204-015-1459-z. Epub 2015 Jan 25. Arch Toxicol. 2015. PMID: 25618545 Review.
-
Mutants of the tumour suppressor p53 L1 loop as second-site suppressors for restoring DNA binding to oncogenic p53 mutations: structural and biochemical insights.Biochem J. 2010 Mar 29;427(2):225-36. doi: 10.1042/BJ20091888. Biochem J. 2010. PMID: 20113312
-
Recent advances in understanding apoptosis: new therapeutic opportunities in cancer chemotherapy.Trends Mol Med. 2003 Jun;9(6):251-5. doi: 10.1016/s1471-4914(03)00084-4. Trends Mol Med. 2003. PMID: 12829013
-
p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.Cell Rep. 2013 May 30;3(5):1339-45. doi: 10.1016/j.celrep.2013.04.012. Epub 2013 May 9. Cell Rep. 2013. PMID: 23665218
Cited by
-
Rationally designed fluorogenic protease reporter visualizes spatiotemporal dynamics of apoptosis in vivo.Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):3338-43. doi: 10.1073/pnas.1502857112. Epub 2015 Mar 2. Proc Natl Acad Sci U S A. 2015. PMID: 25733847 Free PMC article.
-
Transcriptional profiling of PRKG2-null growth plate identifies putative down-stream targets of PRKG2.BMC Res Notes. 2015 Apr 30;8:177. doi: 10.1186/s13104-015-1136-6. BMC Res Notes. 2015. PMID: 25924610 Free PMC article.
-
MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation.Oncogene. 2017 Mar 30;36(13):1760-1769. doi: 10.1038/onc.2016.350. Epub 2016 Oct 17. Oncogene. 2017. PMID: 27748758 Free PMC article.
-
Radioiodide induces apoptosis in human thyroid tissue in culture.Endocrine. 2013 Dec;44(3):729-34. doi: 10.1007/s12020-013-9940-z. Epub 2013 Mar 31. Endocrine. 2013. PMID: 23543460
-
Alternative RNA splicing and cancer.Wiley Interdiscip Rev RNA. 2013 Sep-Oct;4(5):547-66. doi: 10.1002/wrna.1178. Epub 2013 Jun 13. Wiley Interdiscip Rev RNA. 2013. PMID: 23765697 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources